Ultimovacs ASA reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was NOK 43.38 million compared to NOK 22.38 million a year ago. Basic loss per share from continuing operations was NOK 1.3 compared to NOK 0.7 a year ago.
For the six months, net loss was NOK 77.49 million compared to NOK 58.98 million a year ago. Basic loss per share from continuing operations was NOK 2.3 compared to NOK 1.7 a year ago.